Steep rise in adverse drug reactions

The other day the Schwartz Report had a link to a story in the Wall Street Journal written by Jennifer Corbett Dooren, titled Study Shows Steep Rise In Adverse Drug Reactions. In the eight year period from 1998 to 2005 the number of serious drug side effects reported to the FDA more than doubled.

According to the story:

A serious adverse drug event, defined by the FDA, means an event that resulted in death, a birth defect, disability, hospitalization, was life-threatening or required medical intervention to prevent harm.

From 1998 to 2005, there were 467,809 serious adverse events reported. The annual number of reports rose from 34,966 in 1998 to 89,842 in 2005 [250% increase] while the number of fatal adverse drug events increased from 5,519 to 15,107 [274% increase] in the same time frame.

The study noted that, overall, the relative increase in serious reports was four times faster [400% increase] than the growth in total U.S. outpatient prescriptions, which grew in the same period from 2.7 billion to 3.8 billion [140% increase].

So, what has changed to cause this remarkable increase in adverse reaction? We’ve changed – are changing. The shift in consciousness that has been talked about for years is happening, and with that change in consciousness comes a change in our physical manifestations – our bodies. One cannot be separated from the other; changes in one cause changes in the other. It should be noted that from the moment mankind appeared on earth, our consciousness has been shifting – changing – but that shift is now accelerating.

More and more people are seeking alternative solutions to health-related problems such as Acupuncture, visualization exercises and meditation. Some insurance companies have even started covering part of the cost of Acupuncture treatments. Sales of vitamin and herbal supplements continue to rise. The pharmaceutical industry is quietly – and not so quietly – trying to gain control over the vitamin and herbal supplements industries.

The pharmaceutical companies and their trade associations have a very powerful lobby, and according to kaisernetwork.org, and the Center for Public Integrity, between January 2005 and June 2006, they spent a record total of $155 million lobbying Congress, and that number will grow considerably in the future. The article goes on to report that from an industry perspective, it’s money well spent as it has allowed them to win virtually every important battle. Add to that their campaign contributions and “We The People” don’t have much of a chance.

“We The People” don’t have a lobby. I strongly recommend you read the linked articles above.